» Articles » PMID: 23012361

Activity, Specificity, and Probe Design for the Smallpox Virus Protease K7L

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2012 Sep 27
PMID 23012361
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The K7L gene product of the smallpox virus is a protease implicated in the maturation of viral proteins. K7L belongs to protease Clan CE, which includes distantly related cysteine proteases from eukaryotes, pathogenic bacteria, and viruses. Here, we describe its recombinant high level expression, biochemical mechanism, substrate preference, and regulation. Earlier studies inferred that the orthologous I7L vaccinia protease cleaves at an AG-X motif in six viral proteins. Our data for K7L suggest that the AG-X motif is necessary but not sufficient for optimal cleavage activity. Thus, K7L requires peptides extended into the P7 and P8 positions for efficient substrate cleavage. Catalytic activity of K7L is substantially enhanced by homodimerization, by the substrate protein P25K as well as by glycerol. RNA and DNA also enhance cleavage of the P25K protein but not of synthetic peptides, suggesting that nucleic acids augment the interaction of K7L with its protein substrate. Library-based peptide preference analyses enabled us to design an activity-based probe that covalently and selectively labels K7L in lysates of transfected and infected cells. Our study thus provides proof-of-concept for the design of inhibitors and probes that may contribute both to a better understanding of the role of K7L in the virus life cycle and the design of novel anti-virals.

Citing Articles

Yeast-Based Screening of Anti-Viral Molecules.

Srivastava V, Kumar R, Ahmad A Microorganisms. 2024; 12(3).

PMID: 38543629 PMC: 10974075. DOI: 10.3390/microorganisms12030578.


Targeting the I7L Protease: A Rational Design for Anti-Monkeypox Drugs?.

Dodaro A, Pavan M, Moro S Int J Mol Sci. 2023; 24(8).

PMID: 37108279 PMC: 10138331. DOI: 10.3390/ijms24087119.


Viral proteases as therapeutic targets.

Majerova T, Konvalinka J Mol Aspects Med. 2022; 88:101159.

PMID: 36459838 PMC: 9706241. DOI: 10.1016/j.mam.2022.101159.


Precursors of Viral Proteases as Distinct Drug Targets.

Majerova T, Novotny P Viruses. 2021; 13(10).

PMID: 34696411 PMC: 8537868. DOI: 10.3390/v13101981.


Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design.

Rut W, Lv Z, Zmudzinski M, Patchett S, Nayak D, Snipas S Sci Adv. 2020; 6(42).

PMID: 33067239 PMC: 7567588. DOI: 10.1126/sciadv.abd4596.


References
1.
Lopez-Otin C, Simon-Mateo C, Martinez L, Vinuela E . Gly-Gly-X, a novel consensus sequence for the proteolytic processing of viral and cellular proteins. J Biol Chem. 1989; 264(16):9107-10. View

2.
Ansarah-Sobrinho C, Moss B . Role of the I7 protein in proteolytic processing of vaccinia virus membrane and core components. J Virol. 2004; 78(12):6335-43. PMC: 416539. DOI: 10.1128/JVI.78.12.6335-6343.2004. View

3.
Bayliss C, Smith G . Vaccinia virion protein VP8, the 25 kDa product of the L4R gene, binds single-stranded DNA and RNA with similar affinity. Nucleic Acids Res. 1997; 25(20):3984-90. PMC: 147007. DOI: 10.1093/nar/25.20.3984. View

4.
Rawlings N, Morton F, Kok C, Kong J, Barrett A . MEROPS: the peptidase database. Nucleic Acids Res. 2007; 36(Database issue):D320-5. PMC: 2238837. DOI: 10.1093/nar/gkm954. View

5.
Byrd C, Bolken T, Hruby D . The vaccinia virus I7L gene product is the core protein proteinase. J Virol. 2002; 76(17):8973-6. PMC: 136993. DOI: 10.1128/jvi.76.17.8973-8976.2002. View